FDA Device Intelligence
HomeLUMINEX CORPORATION › FLEXMAP 3D®

FLEXMAP 3D®

LUMINEX CORPORATION · Model FLEXMAP 3D · UDI-DI 00840487100301

NSU Prescription
2
510(k) clearances
139
Adverse events
13
Recalls
62
Facilities

Description

The FLEXMAP 3D® system is a compact analyzer that performs up to 500 analytes from a single sample. The instrument includes four subsystems: electronic, fluidic, mechanical, and optical; and utilizes xPONENT® software version 4.0 SP1 of the xMAP® (Multi-Analyte Profiling) technology operating system. The electronics system provides the power for operation and control of the FLEXMAP 3D system and communication between its parts. The fluidics system handles the flow of liquid through the Luminex® FLEXMAP 3D® instrument. The mechanical subsystem of the Luminex® FLEXMAP 3D® instrument includes a filter system used to aid in cooling of the instrument and pressurized sheath fluid. The optical sub-system consists of the optical assembly and excitation lasers and does not require manual adjustment by the user

Recalls

DateFirmReason
2025-06-25Nuclein LLCDue to a software issue which may result in false co-infection (e.g., Positive for Flu A, when SARS-CoV-2 is present).
2024-08-07BioFire Diagnostics, LLCSome automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and
2023-10-17BioFire Diagnostics, LLCDue to an increased risk of degradation of the power entry switch resulting from arcing inside of the power switch that may result in carbon build-up on the switch contacts. The ca
2022-09-08Roche Molecular Systems, Inc.Reported false positive and invalid results on the affected devices due to anomalous baselines. This may lead to erroneous or delayed diagnoses.
2021-02-26Hologic, IncThere is a potential for tube trays to leak which could potentially result in false positive results, false negative results or invalid patient results.
2020-08-04Hologic, IncTube trays may leak which could invalidate patient results or assay worklists, causing delayed results for any assays with which they are used. A possibility exists of false negati
2019-04-22Luminex CorporationTwo of three complaints were initiated due to the customers repeatedly obtaining No Call results on the Processor SPs in question.
2018-01-20Hologic, IncThe Panther or the Panther Fusion glass panel separates from the 19 inch touch screen monitor and could potentially fall and hit an operator.
2017-09-15Hologic, IncAn incorrect incubator was installed on one Panther System which potentially led to incorrect Aptima Combo 2(R) assay (AC2) results.
2017-07-18Becton Dickinson & Co.BD recently notified customers in July 2017 regarding an increased rate of unresolved (UNR) and indeterminate (IND) results for the BD MAXTM Vaginal Panel, experienced by some cust

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.